' '
Deutsch | English    

Forschungsdatenbank PMU-SQQUID

WALLY VERENA
Universitätsklinik für Dermatologie
Forschungsprogramm für Molekulare Therapie bei Genodermatosen

Publikationen | Forscherprofil

98 Publikationen

2022

Beiträge in Fachzeitschriften

Paired nicking-mediated COL17A1 reframing for junctional epidermolysis bullosa.
Bischof, J; March, OP; Liemberger, B; Haas, SA; Hainzl, S; Petković, I; Leb-Reichl, V; Illmer, J; Korotchenko, E; Klausegger, A; Hoog, A; Binder, HM; Garcia, M; Duarte, B; Strunk, D; Larcher, F; Reichelt, J; Guttmann-Gruber, C; Wally, V; Hofbauer, JP; Bauer, JW; Cathomen, T; Kocher, T; Koller, U;
Mol Ther. 2022; 30(8): 2680-2692.
Originalarbeiten (Zeitschrift)
Chondroitin Sulfate Proteoglycan 4 as a Marker for Aggressive Squamous Cell Carcinoma
Chen, K; Yong, J; Zauner, R; Wally, V; Whitelock, J; Sajinovic, M; Kopecki, Z; Liang, K; Scott, KF; Mellick, AS
CANCERS. 2022; 14(22): 5564
Übersichtsarbeiten
5'RNA Trans-Splicing Repair of COL7A1 Mutant Transcripts in Epidermolysis Bullosa
Mayr, E; Ablinger, M; Lettner, T; Murauer, EM; Guttmann-Gruber, C; Piñón Hofbauer, J; Hainzl, S; Kaiser, M; Klausegger, A; Bauer, JW; Koller, U; Wally, V;
Int J Mol Sci. 2022; 23(3):
Originalarbeiten (Zeitschrift)
COL17A1 editing via homology-directed repair in junctional epidermolysis bullosa.
Petković, I; Bischof, J; Kocher, T; March, OP; Liemberger, B; Hainzl, S; Strunk, D; Raninger, AM; Binder, HM; Reichelt, J; Guttmann-Gruber, C; Wally, V; Piñón Hofbauer, J; Bauer, JW; Koller, U;
Front Med (Lausanne). 2022; 9: 976604
Originalarbeiten (Zeitschrift)
Evaluating a Targeted Cancer Therapy Approach Mediated by RNA trans-Splicing In Vitro and in a Xenograft Model for Epidermolysis Bullosa-Associated Skin Cancer
Woess, K; Sun, Y; Morio, H; Stierschneider, A; Kaufmann, A; Hainzl, S; Trattner, L; Kocher, T; Tockner, B; Leb-Reichl, V; Steiner, M; Brachtl, G; South, AP; Bauer, JW; Reichelt, J; Furihata, T; Wally, V; Koller, U; Piñón Hofbauer, J; Guttmann-Gruber, C;
Int J Mol Sci. 2022; 23(1):
Originalarbeiten (Zeitschrift)
Transcriptome-Guided Drug Repurposing for Aggressive SCCs.
Zauner, R; Wimmer, M; Dorfer, S; Ablinger, M; Koller, U; Piñón Hofbauer, J; Guttmann-Gruber, C; Bauer, JW; Wally, V;
Int J Mol Sci. 2022; 23(2):
Originalarbeiten (Zeitschrift)

2021

Beiträge in Fachzeitschriften

Personalized Development of Antisense Oligonucleotides for Exon Skipping Restores Type XVII Collagen Expression in Junctional Epidermolysis Bullosa.
Ablinger, M; Lettner, T; Friedl, N; Potocki, H; Palmetzhofer, T; Koller, U; Illmer, J; Liemberger, B; Hainzl, S; Klausegger, A; Reisenberger, M; Lambert, J; Van Gele, M; Desmet, E; Van Maelsaeke, E; Wimmer, M; Zauner, R; Bauer, JW; Wally, V;
Int J Mol Sci. 2021; 22(7):
Originalarbeiten (Zeitschrift)
QR-313, an Antisense Oligonucleotide, Shows Therapeutic Efficacy for Treatment of Dominant and Recessive Dystrophic Epidermolysis Bullosa: A Preclinical Study.
Bornert, O; Hogervorst, M; Nauroy, P; Bischof, J; Swildens, J; Athanasiou, I; Tufa, SF; Keene, DR; Kiritsi, D; Hainzl, S; Murauer, EM; Marinkovich, MP; Platenburg, G; Hausser, I; Wally, V; Ritsema, T; Koller, U; Haisma, EM; Nyström, A;
J Invest Dermatol. 2021; 141(4):883-893.e6
Originalarbeiten (Zeitschrift)
Epigenetic and metabolic regulation of epidermal homeostasis.
Wagner, RN; Piñón Hofbauer, J; Wally, V; Kofler, B; Schmuth, M; De Rosa, L; De Luca, M; Bauer, JW;
Exp Dermatol. 2021; 30(8): 1009-1022.
Übersichtsarbeiten

Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

Development of a non-invasive and non-viral in vivo RNA therapy approach for dystrophic epidermolysis bullosa
Liemberger, B; Kocher, T; Lettner, T; Ablinger, M; Reichl, V; Lackner, N; Peking, P; Murauer, EM; Nystrom, A; Wally, V; Mayr, E; Guttmann-Gruber, C; Bauer, JW; Koller, U
EXP DERMATOL. 2021; 30(3): E43-E43.
Abstracts (Zeitschrift)

Beiträge in Sonstigen Zeitschriften

Erforschung von miRNAs bei aggressiven Plattenepithelkarzinomen
Ablinger, M; Wally, V; Zauner, R; Wimmer, M;
Spectrum Dermatologie. 2021.

2020

Beiträge in Fachzeitschriften

Small molecule drug development for rare genodermatoses - evaluation of the current status in epidermolysis bullosa.
Wally, V; Reisenberger, M; Kitzmüller, S; Laimer, M;
Orphanet J Rare Dis. 2020; 15(1): 292
Übersichtsarbeiten
A cancer stem cell-like phenotype is associated with miR-10b expression in aggressive squamous cell carcinomas.
Wimmer, M; Zauner, R; Ablinger, M; Piñón-Hofbauer, J; Guttmann-Gruber, C; Reisenberger, M; Lettner, T; Niklas, N; Proell, J; Sajinovic, M; De Souza, P; Hainzl, S; Kocher, T; Murauer, EM; Bauer, JW; Strunk, D; Reichelt, J; Mellick, AS; Wally, V;
Cell Commun Signal. 2020; 18(1): 61
Originalarbeiten (Zeitschrift)

Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

MIR-10B AS A MARKER FOR DISSEMINATED DISEASE IN RDEB-LINKED SCCS
Shah, MM; Bodocian, H; Zauner, R; Sajinovic, M; De Souza, P; Wally, V; Mellick, AS
ACTA DERM-VENEREOL. 2020; 100: 60-61.
Abstracts (Zeitschrift)
MIRNA-10B MARKS AGGRESSIVE SQUAMOUS CELL CARCINOMAS IN RDEB
Wimmer, M; Zauner, R; Ablinger, M; Pinon-Hofbauer, J; Guttmann-Gruber, C; Reisenberger, M; Lettner, T; Niklas, N; Proell, J; Sajinovic, M; De Souza, P; Hainzl, S; Murauer, EM; Bauer, JW; Strunk, D; Reichelt, J; Mellick, AS; Wally, V
ACTA DERM-VENEREOL. 2020; 100: 35-36.
Abstracts (Zeitschrift)
CIRCULATING CELL-FREE MIRNA SCREENING FOR RDEB-SCC BIOMARKER IDENTIFICATION
Zauner, R; Wimmer, M; Ablinger, M; Lettner, T; Atzmuller, S; Proll, J; Bauer, JW; Wally, V
ACTA DERM-VENEREOL. 2020; 100: 37-37.
Abstracts (Zeitschrift)

2019

Beiträge in Fachzeitschriften

Contradictory effects of chemical filters in UV/ROS-stressed human keratinocyte and fibroblast cells.
Hofer, S; Stonig, M; Wally, V; Hartmann, A; Fuchs, D; Hermann, M; Paparella, M; Ganzera, M; Gostner, JM;
ALTEX. 2019; 36(2):231-244
Originalarbeiten (Zeitschrift)
An ex vivo RNA trans-splicing strategy to correct human generalized severe epidermolysis bullosa simplex.
Peking, P; Breitenbach, JS; Ablinger, M; Muss, WH; Poetschke, FJ; Kocher, T; Koller, U; Hainzl, S; Kitzmueller, S; Bauer, JW; Reichelt, J; Lettner, T; Wally, V;
Br J Dermatol. 2019; 180(1):141-148
Originalarbeiten (Zeitschrift)
MicroRNAs: one for all, all for one.
Wally, V; Bauer, JW;
Br J Dermatol. 2019; 181(5): 890-891.
Kommentare

Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

Correction of type XVII collagen using spliceosome-mediated RNA trans-splicing
Reisenberger, M; Schlager, P; Reichelt, J; Bauer, JW; Koller, U; Hainzl, S; Ablinger, M; Lettner, T; Wally, V
EUR J HUM GENET. 2019; 27: 109-110.
Abstracts (Zeitschrift)
Major player in miRNA processing appear altered in recessive dystrophic epidermolysis bullosa squamous cell carcinoma
Wimmer, M; Zauner, R; Waldmann, A; Bodocian, H; Ablinger, M; Atzmueller, S; Proell, J; Strunk, D; Bauer, JW; Reichelt, J; Wally, V
EUR J HUM GENET. 2019; 27: 109-109.
Abstracts (Zeitschrift)
Application of a machine learning approach to identify miRNA fingerprint signatures in recessive dystrophic epidermolysis bullosa
Zauner, R; Wimmer, M; Lettner, T; Atzmuller, S; Proll, J; Guttmann-Gruber, C; Murauer, EM; Reichelt, J; Strunk, D; Bauer, JW; Wally, V
EUR J HUM GENET. 2019; 27: 108-109.
Abstracts (Zeitschrift)

2018

Beiträge in Fachzeitschriften

Basal pharmacokinetic parameters of topically applied diacerein in pediatric patients with generalized severe epidermolysis bullosa simplex.
Ablinger, M; Felder, TK; Wimmer, M; Zauner, R; Hofbauer, P; Lettner, T; Wolkersdorfer, M; Lagler, FB; Diem, A; Bauer, JW; Wally, V;
Orphanet J Rare Dis. 2018; 13(1): 193
Letter
RNA Trans-Splicing Modulation via Antisense Molecule Interference.
Liemberger, B; Piñón Hofbauer, J; Wally, V; Arzt, C; Hainzl, S; Kocher, T; Murauer, EM; Bauer, JW; Reichelt, J; Koller, U;
Int J Mol Sci. 2018; 19(3):
Originalarbeiten (Zeitschrift)
Threonine 150 Phosphorylation of Keratin 5 Is Linked to Epidermolysis Bullosa Simplex and Regulates Filament Assembly and Cell Viability.
Sawant, M; Schwarz, N; Windoffer, R; Magin, TM; Krieger, J; Mücke, N; Obara, B; Jankowski, V; Jankowski, J; Wally, V; Lettner, T; Leube, RE;
J Invest Dermatol. 2018; 138(3):627-636
Originalarbeiten (Zeitschrift)
Extracellular Vesicles as Biomarkers for the Detection of a Tumor Marker Gene in Epidermolysis Bullosa-Associated Squamous Cell Carcinoma.
Sun, Y; Woess, K; Kienzl, M; Leb-Reichl, VM; Feinle, A; Wimmer, M; Zauner, R; Wally, V; Luetz-Meindl, U; Mellerio, JE; Fuentes, I; South, AP; Bauer, JW; Reichelt, J; Furihata, T; Guttmann-Gruber, C; Piñón Hofbauer, J;
J Invest Dermatol. 2018; 138(5):1197-1200
Letter
Diacerein orphan drug development for epidermolysis bullosa simplex: A phase 2/3 randomized, placebo-controlled, double-blind clinical trial.
Wally, V; Hovnanian, A; Ly, J; Buckova, H; Brunner, V; Lettner, T; Ablinger, M; Felder, TK; Hofbauer, P; Wolkersdorfer, M; Lagler, FB; Hitzl, W; Laimer, M; Kitzmüller, S; Diem, A; Bauer, JW;
J Am Acad Dermatol. 2018; 78(5): 892-901.e7.
Originalarbeiten (Zeitschrift)

2017

Beiträge in Fachzeitschriften

Cut and Paste: Efficient Homology-Directed Repair of a Dominant Negative KRT14 Mutation via CRISPR/Cas9 Nickases.
Kocher, T; Peking, P; Klausegger, A; Murauer, EM; Hofbauer, JP; Wally, V; Lettner, T; Hainzl, S; Ablinger, M; Bauer, JW; Reichelt, J; Koller, U;
Mol Ther. 2017; 25(11):2585-2598
Originalarbeiten (Zeitschrift)
Synergistic effects of dendritic cell targeting and laser-microporation on enhancing epicutaneous skin vaccination efficacy.
Machado, Y; Duinkerken, S; Hoepflinger, V; Mayr, M; Korotchenko, E; Kurtaj, A; Pablos, I; Steiner, M; Stoecklinger, A; Lübbers, J; Schmid, M; Ritter, U; Scheiblhofer, S; Ablinger, M; Wally, V; Hochmann, S; Raninger, AM; Strunk, D; van Kooyk, Y; Thalhamer, J; Weiss, R;
J Control Release. 2017; 266:87-99
Originalarbeiten (Zeitschrift)

Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

Topically applied diacerein: Basic pharmacokinetics in generalized-severe epidermolysis bullosa simplex
Ablinger, M; Felder, T; Wimmer, M; Zauner, R; Hofbauer, P; Wolkersdorfer, M; Lagler, F; Diem, A; Bauer, JW; Wally, V
J INVEST DERMATOL. 2017; 137(10): S198-S198.
Abstracts (Zeitschrift)
Highly efficient and safe CRISPR/Cas9n double nicking-mediated KRT14 repair in epidermolysis bullosa simplex keratinocytes
Kocher, T; Peking, P; Klausegger, A; Murauer, EM; Hofbauer, JP; Wally, V; Lettner, T; Hainzl, S; Ablinger, M; Bauer, JW; Reichelt, J; Koller, U
HUM GENE THER. 2017; 28(12): A57-A57.
Abstracts (Zeitschrift)
Improved safety profile: An efficient CRISPR/Cas9 double nicking approach for KRT14 repair in EB simplex
Kocher, T; Peking, P; Klausegger, A; Murauer, EM; Hofbauer, JP; Wally, V; Lettner, T; Hainzl, S; Ablinger, M; Bauer, JW; Reichelt, J; Koller, U
J INVEST DERMATOL. 2017; 137(10): S225-S225.
Abstracts (Zeitschrift)
Combining antisense molecules with splicing modulation for KRT14 repair in epidermolysis bullosa
Liemberger, B; Arzt, C; Hainzl, S; Pinon Hofbauer, J; Wally, V; Murauer, EM; Bauer, JW; Reichelt, J; Koller, U
Journal of Investigative Dermatology. 2017; S189: -Annual Meeting of the European Society for Dermatological Research; 27.-30.09.2017; Salzburg.
Abstracts (Zeitschrift)
Enhanced genome editing using split Staphylococcus aureus Cas9 delivered in self-complementary AAV vectors
Liemberger, B; Arzt, C; Hainzl, S; Wally, V; Kocher, T; Hofbauer, JP; Murauer, EM; Bauer, JW; Reichelt, J; Koller, U
HUM GENE THER. 2017; 28(12): A63-A63.
Abstracts (Zeitschrift)
Altering the splice pattern of COL17A1 with antisense oligonucleotides
Potocki, H; Lettner, T; Ablinger, M; Wimmer, M; Zauner, R; Friedl, N; Reichelt, J; Bauer, JW; Wally, V
J INVEST DERMATOL. 2017; 137(10): S227-S227.
Abstracts (Zeitschrift)
Extracellular vesicles as biomarkers for the detection of epidermolysis bullosa-associated squamous cell carcinoma
Sun, Y; Woess, K; Wimmer, M; Zauner, R; Feinle, A; Wally, V; South, A; Furihata, T; Hofbauer, JP; Gruber, C
J INVEST DERMATOL. 2017; 137(10): S288-S288.
Abstracts (Zeitschrift)
Deregulation of miR-10b affects HOXD10 expression in squamous cell carcinoma from epidermolysis bullosa patients
Wimmer, M; Zauner, R; Lettner, T; Niklas, N; Atzmuller, S; Reichelt, J; Bauer, JW; Wally, V
J INVEST DERMATOL. 2017; 137(10): S294-S294.
Abstracts (Zeitschrift)
Transcriptome profiling in recessive dystrophic epidermolysis bullosa patients
Zauner, R; Wimmer, M; Lettner, T; Gruber, C; Murauer, EM; Reichelt, J; Strunk, D; Bauer, JW; Wally, V
J INVEST DERMATOL. 2017; 137(10): S288-S288.
Abstracts (Zeitschrift)

2016

Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

A murine transplantation model for trans-splicing corrected human keratinocytes
Ablinger, M; Breitenbach, JS; Lettner, T; Muss, W; Peking, P; Hainzl, S; Kocher, T; Kitzmuller, SK; Reichelt, J; Bauer, JW; Wally, V
HUM GENE THER. 2016; 27(11): A184-A184.
Abstracts (Zeitschrift)
Combining antisense molecules with splicing modulation for KRT14 repair in epidermolysis bullosa
Liemberger, B; Arzt, C; Hainzl, S; Hofbauer, JP; Wally, V; Murauer, EM; Bauer, JW; Reichelt, J; Koller, U
J INVEST DERMATOL. 2016; 136(9): S189-S189.
Abstracts (Zeitschrift)
Antisense RNA-mediated improvement of SMaRT therapy for KRT14 correction
Liemberger, B; Arzt, C; Hainzl, S; Hofbauer, JP; Wally, V; Murauer, EM; Bauer, JW; Reichelt, J; Koller, U
HUM GENE THER. 2016; 27(11): A135-A135.
Abstracts (Zeitschrift)
miRNA-10 as potential therapeutic target in recessive dystrophic epidermolysis bullosa
Wimmer, M; Zauner, R; Lettner, T; Niklas, N; Atzmuller, S; Reichelt, J; Bauer, JW; Wally, V
J INVEST DERMATOL. 2016; 136(9): S172-S172.
Abstracts (Zeitschrift)
miRNAs as potential players RDEB cancer development
Wimmer, M; Zauner, R; Lettner, T; Niklas, N; Proll, J; Bauer, JW; Reichelt, J; Wally, V
MELANOMA RES. 2016; 26: E70-E70.
Abstracts (Zeitschrift)
Micro RNAs as a disease modifier in recessive dystrophic epidermolysis bullosa
Wimmer, M; Zauner, R; Lettner, T; Niklas, N; Reichelt, J; Wally, V
EXP DERMATOL. 2016; 25(3): E14-E14.
Abstracts (Zeitschrift)
Identification of isomiRs in recessive dystrophic epidermolysis bullosa
Zauner, R; Wimmer, M; Lettner, T; Niklas, N; Atzmuller, S; Reichelt, J; Bauer, JW; Wally, V
J INVEST DERMATOL. 2016; 136(9): S187-S187.
Abstracts (Zeitschrift)
Identification of functional microRNA - mRNA regulatory modules in recessive dystrophic epidermolysis bullosa
Zauner, R; Wimmer, M; Lettner, T; Reichelt, J; Wally, V
EXP DERMATOL. 2016; 25(3): E15-E15.
Abstracts (Zeitschrift)

2015

Beiträge in Fachzeitschriften

Trans-splicing improvement by the combined application of antisense strategies.
Koller, U; Hainzl, S; Kocher, T; Hüttner, C; Klausegger, A; Gruber, C; Mayr, E; Wally, V; Bauer, JW; Murauer, EM;
Int J Mol Sci. 2015; 16(1):117-191
Originalarbeiten (Zeitschrift)
Increased levels of matrix metalloproteinase-9 and interleukin-8 in blister fluids of dystrophic and junctional epidermolysis bullosa patients.
Lettner, T; Lang, R; Bauer, JW; Wally, V;
J Eur Acad Dermatol Venereol. 2015; 29(2): 396-398.
Letter
Urine is a novel source of autologous mesenchymal stem cells for patients with epidermolysis bullosa.
Schosserer, M; Reynoso, R; Wally, V; Jug, B; Kantner, V; Weilner, S; Buric, I; Grillari, J; Bauer, JW; Grillari-Voglauer, R;
BMC Res Notes. 2015; 8(1): 767
Originalarbeiten (Zeitschrift)

Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

Trans-splicing gene therapy in the KRT14 gene
Breitenbach, JS; Lettner, T; Kocher, T; Muss, W; Peking, P; Hainzl, S; Kitzmuller, SK; Ablinger, M; Potschke, FJ; Bauer, JW; Wally, V
HUM GENE THER. 2015; 26(10): A44-A44.
Abstracts (Zeitschrift)
Antisense Oligonucleotide therapy for the correction of COL17A1 splicing in junctional epidermolysis bullosa
Friedl, N; Lettner, T; Bauer, J; Wally, V
J INVEST DERMATOL. 2015; 135: S57-S57.
Abstracts (Zeitschrift)
A fluorescence-based screening system accelerates the design of RNA trans-splicing molecules for mRNA repair.
Kocher, T; Koller, U; Seyr, J; Hainzl, S; Mayer, E; Brachtl, G; Lener, T; Bauer, J; Wally, V; Murauer, E
J INVEST DERMATOL. 2015; 135: S60-S60.
Abstracts (Zeitschrift)
Analysis of binding characteristics of RNA trans-splicing molecules using a fluorescence-based screening system
Koller, U; Kocher, T; Seyr, J; Hainzl, S; Mayr, E; Tockner, B; Brachtl, G; Bauer, JW; Wally, V; Murauer, EM
EXP DERMATOL. 2015; 24(3): E16-E17.
Abstracts (Zeitschrift)
Pathological mechanisms underlying contracture formation in epidermolysis bullosa
Liemberger, B; Hainzl, S; Koller, U; Wally, V; Hofbauer, JP; Studnicka-Benke, A; Diem, A; Bauer, J; Breitenbach, J; Gruber, C
J INVEST DERMATOL. 2015; 135: S59-S59.
Abstracts (Zeitschrift)
Development of a luciferase reporter system for small molecule library screening with Dowling-Meara patient cell lines
Poetschke, FJ; Lettner, T; Bauer, J; Wally, V
J INVEST DERMATOL. 2015; 135: S58-S58.
Abstracts (Zeitschrift)
Micro-RNA signatures in recessive dystrophic epidermolysis bullosa
Zauner, R; Wimmer, M; Bauer, J; Lettner, T; Wally, V
J INVEST DERMATOL. 2015; 135: S61-S61.
Abstracts (Zeitschrift)

2014

Beiträge in Fachzeitschriften

Considerations for a Successful RNA Trans-splicing Repair of Genetic Disorders.
Koller, U; Wally, V; Bauer, JW; Murauer, EM;
Mol Ther Nucleic Acids. 2014; 3: e157
Originalarbeiten (Zeitschrift)

Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

Selection of antisense oligonucleotides for trans-splicing enhancement using a fluorescence-based screening system
Koller, U; Hainzl, S; Huttner, C; Kocher, T; Klausegger, A; Murauer, EM; Gruber, C; Mayr, E; Wally, V; Bauer, JW
J INVEST DERMATOL. 2014; 134: S61-S61.
Abstracts (Zeitschrift)
3exon replacement for COL17A1
Reisenberger, M; Schlager, P; Hintner, H; Bauer, J; Wally, V
EXP DERMATOL. 2014; 23(3): E22-E22.
Abstracts (Zeitschrift)

2013

Beiträge in Fachzeitschriften

RNA trans-splicing for genodermatoses.
Bauer, JW; Murauer, EM; Wally, V; Koller, U;
Methods Mol Biol. 2013; 961:441-455
Originalarbeiten (Zeitschrift)
MMP-9 and CXCL8/IL-8 Are Potential Therapeutic Targets in Epidermolysis Bullosa Simplex.
Lettner, T; Lang, R; Klausegger, A; Hainzl, S; Bauer, JW; Wally, V;
PLoS One. 2013; 8(7):e70123
Originalarbeiten (Zeitschrift)
A reporter-based screen to identify potent 3" trans-splicing molecules for endogenous RNA repair.
Murauer, EM; Koller, U; Hainzl, S; Wally, V; Bauer, JW;
Hum Gene Ther Methods. 2013; 24(1):19-27
Originalarbeiten (Zeitschrift)
Topical diacerein for epidermolysis bullosa: a randomized controlled pilot study.
Wally, V; Kitzmueller, S; Lagler, F; Moder, A; Hitzl, W; Wolkersdorfer, M; Hofbauer, P; Felder, TK; Dornauer, M; Diem, A; Eiler, N; Bauer, JW;
Orphanet J Rare Dis. 2013; 8:69
Originalarbeiten (Zeitschrift)
The pathogenetic role of IL-1β in severe epidermolysis bullosa simplex.
Wally, V; Lettner, T; Peking, P; Peckl-Schmid, D; Murauer, EM; Hainzl, S; Hintner, H; Bauer, JW;
J Invest Dermatol. 2013; 133(7):1901-1903
Letter

Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

Pre-screening of trans-splicing molecules improves COL7A1 mRNA repair
Murauer, EM; Koller, U; Hainzl, S; Wally, V; Bauer, JW
HUM GENE THER. 2013; 24(12): A130-A131.
Abstracts (Zeitschrift)

2012

Beiträge in Fachzeitschriften

Spliceosome-mediated trans-splicing: the therapeutic cut and paste.
Wally, V; Murauer, EM; Bauer, JW;
J Invest Dermatol. 2012; 132(8):1959-1966
Übersichtsarbeiten

Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

Optimized high throughput screening system for RNA trans-splicing molecules for gene correction in epidermolysis bullosa
Hainzl, S; Koller, U; Murauer, E; Tockner, B; Wally, V; Hintner, H; Bauer, J
J INVEST DERMATOL. 2012; 132: S94-S94.
Abstracts (Zeitschrift)
Double RNA trans-splicing induced gene correction in epidermolysis bullosa
Koller, U; Hainzl, S; Klausegger, A; Wally, V; Murauer, EM; Mayr, E; Gruber, C; Mitchell, L; Hintner, H; Bauer, JW
J INVEST DERMATOL. 2012; 132: S93-S93.
Abstracts (Zeitschrift)
Molecular pathomechanisms in Dowling-Meara type epidermolysis bullosa simplex cell lines
Lettner, T; Bauer, JW; Wally, V; Hintner, H
EXP DERMATOL. 2012; 21(3): e7-e7.
Abstracts (Zeitschrift)
Screening for highly efficient RTMs to improve 3 xxx trans-splicing for COL7A1 gene
Tockner, B; Murauer, EM; Mayr, E; Wally, V; Koller, U; Hainzl, S; Hintner, H; Bauer, JW
J INVEST DERMATOL. 2012; 132: S95-S95.
Abstracts (Zeitschrift)
IL-1beta as a therapeutic target in Epidermolysis bullosa simplex
Wally, V; Lettner, T; Klausegger, A; Hainzl, S; Hintner, H; Bauer, JW
J INVEST DERMATOL. 2012; 132: S50-S50.
Abstracts (Zeitschrift)
Targeting IL-1 beta for the treatment of EBS-DM
Wally, V; Lettner, T; Peckl-Schmid, D; Klausegger, A; Hainzl, S; Hintner, H; Bauer, JW
EXP DERMATOL. 2012; 21(3): e6-e6.
Abstracts (Zeitschrift)

2011

Beiträge in Fachzeitschriften

A novel screening system improves genetic correction by internal exon replacement.
Koller, U; Wally, V; Mitchell, LG; Klausegger, A; Murauer, EM; Mayr, E; Gruber, C; Hainzl, S; Hintner, H; Bauer, JW;
Nucleic Acids Res. 2011; 39(16): e108
Originalarbeiten (Zeitschrift)

Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

Screening for high efficient double RNA trans-splicing molecules to exchange a single exon of the COL17A1 gene
Koller, U; Wally, V; Mitchell, LG; Klausegger, A; Murauer, EM; Mayr, E; Gruber, C; Hainzl, S; Hintner, H; Bauer, JW
J INVEST DERMATOL. 2011; 131: S67-S67.
Abstracts (Zeitschrift)
Towards understanding molecular mechanisms in severe epidermolysis bullosa simplex
Lettner, T; Wally, V; Hintner, H; Bauer, JW
J INVEST DERMATOL. 2011; 131: S70-S70.
Abstracts (Zeitschrift)
Optimization of 3 xxx trans-splicing in the type VII Collagen gene
Tockner, B; Murauer, EM; Gruber, C; Mayr, E; Schlager, P; Wally, V; Koller, U; Klausegger, A; Hintner, H; Bauer, JW
HUM GENE THER. 2011; 22(10): A53-A53.
Abstracts (Zeitschrift)

Originalbeiträge in Sammelwerk (Buchbeitrag)

High-Throughput Screening for Highly Functional RNA-Trans-Splicing Molecules: Correction of Plectin in Epidermolysis Bullosa Simplex.
Wally, V; Koller, U; Bauer, JW;
In: Dijana Plaseska-Karanfilska (Ed.) editors(s). Human Genetic Diseases.. (ISBN: 978-953-307-936-3)

2010

Beiträge in Fachzeitschriften

Aberrant heterodimerization of keratin 16 with keratin 6A in HaCaT keratinocytes results in diminished cellular migration.
Trost, A; Desch, P; Wally, V; Haim, M; Maier, RH; Reitsamer, HA; Hintner, H; Bauer, JW; Onder, K;
MECH AGEING DEV. 2010; 131(5): 346-353.
Originalarbeiten (Zeitschrift)
K14 mRNA reprogramming for dominant epidermolysis bullosa simplex.
Wally, V; Brunner, M; Lettner, T; Wagner, M; Koller, U; Trost, A; Murauer, EM; Hainzl, S; Hintner, H; Bauer, JW;
Hum Mol Genet. 2010; 19(23):471-425
Originalarbeiten (Zeitschrift)

Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

Improvement of RNA trans-splicing based gene correction using a RTM screening system
Koller, U; Wally, V; Mitchell, LG; Klausegger, A; Murauer, EM; Mayr, E; Gruber, C; Hintner, H; Bauer, JW
HUM GENE THER. 2010; 21(10): 1451-1451.
Abstracts (Zeitschrift)
Keratin 14 mRNA trans-splicing in dominant Epidermolysis bullosa
Wally, V; Brunner, M; Lettner, T; Koller, U; Hintner, H; Bauer, JW
HUM GENE THER. 2010; 21(10): 1446-1446.
Abstracts (Zeitschrift)

2009

Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

High throughput screening for functional RNA trans-splicing repair molecules (RTMs) for the correction of the gene PLEC1
Koller, U; Wally, V; Mitchell, L; Klausegger, A; Muraurer, E; Mayr, E; Brunner, M; Hintner, H; Bauer, J
HUM GENE THER. 2009; 20(11): 1530-1531.
Abstracts (Zeitschrift)
Using RNA Trans-splicing to correct mutations in the plectin gene
Koller, U; Wally, V; Mitchell, LG; Klausegger, A; Murauer, EM; Mayr, E; Hintner, H; Bauer, JW
EXP DERMATOL. 2009; 18(3): 283-283.
Abstracts (Zeitschrift)
5# Trans-splicing in the type vii collagen gene-development of a mRNA based gene therapy approach for dystrophic epidermolysis bullosa
Mayr, E; Koller, U; Murauer, EM; Wally, V; Klausegger, A; Hintner, H; Bauer, JW
EXP DERMATOL. 2009; 18(3): 284-284.
Abstracts (Zeitschrift)
5 xxx trans-splicing in the Type VII Collagen Gene - Development of a mRNA based Gene Therapy Approach for Dystrophic Epidermolysis bullosa
Mayr, E; Koller, U; Murauer, EM; Wally, V; Klausegger, A; Hintner, H; Bauer, JW
J INVEST DERMATOL. 2009; 129: S46-S46.
Abstracts (Zeitschrift)
3 xxx Trans-splicing as a tool for gene therapy in dystrophic epidermolysis bullosa
Murauer, EM; Gache, Y; Klausegger, A; Wally, V; Koller, U; Mayr, E; Meneguzzi, G; Bauer, JW
EXP DERMATOL. 2009; 18(3): 283-283.
Abstracts (Zeitschrift)
Therapy of dominant Epidermolysis bullosa vie Spliceosome Mediated RNA Trans-splicing
Wally, V; Brunner, M; Koller, U; Hintner, H; Bauer, JW
J INVEST DERMATOL. 2009; 129: S55-S55.
Abstracts (Zeitschrift)
Gene therapy for autosomal dominant diseases
Wally, V; Koller, U; Murauer, EM; Mayr, E; Klausegger, A; Hintner, H; Bauer, JW
EXP DERMATOL. 2009; 18(3): 283-283.
Abstracts (Zeitschrift)

2008

Beiträge in Fachzeitschriften

Cladosporium herbarum translationally controlled tumor protein (TCTP) is an IgE-binding antigen and is associated with disease severity.
Rid, R; Simon-Nobbe, B; Langdon, J; Holler, C; Wally, V; Pöll, V; Ebner, C; Hemmer, W; Hawranek, T; Lang, R; Richter, K; MacDonald, S; Rinnerthaler, M; Laun, P; Mari, A; Breitenbach, M;
MOL IMMUNOL. 2008; 45(2): 406-418.
Originalarbeiten (Zeitschrift)
5" trans-splicing repair of the PLEC1 gene.
Wally, V; Klausegger, A; Koller, U; Lochmüller, H; Krause, S; Wiche, G; Mitchell, LG; Hintner, H; Bauer, JW;
J INVEST DERMATOL. 2008; 128(3): 568-574.
Originalarbeiten (Zeitschrift)

2007

Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

Correction of mutations in the plectin gene by RNA Trans-splicing
Koller, U; Wally, V; Hintner, H; Bauer, JW
HUM GENE THER. 2007; 18(10): 1016-1016.
Abstracts (Zeitschrift)

2006

Beiträge in Fachzeitschriften

Skin grafting as a therapeutic approach in pretibially restricted junctional epidermolysis bullosa.
Laimer, M; Bauer, JW; Klausegger, A; Koller, J; Pohla-Gubo, G; Muss, W; Sadler, E; Emberger, M; Lanschuetzer, CM; Hametner, R; Wally, V; Oender, K; Hinter, H;
BRIT J DERMATOL. 2006; 154(1): 185-187.
Fallberichte
Haploinsufficiency due to deletion within the 3"-UTR of C1-INH-gene associated with hereditary angioedema.
Laimer, M; Klausegger, A; Aberer, W; Oender, K; Steinhuber, M; Lanschuetzer, CM; Wally, V; Hintner, H; Bauer, JW;
GENET MED. 2006; 8(4): 249-254.
Originalarbeiten (Zeitschrift)

Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

Spliceosome mediated RNA trans-splicing (SMaRT) is a novel method to treat autosomal dominant diseases
Wally, V; Klausegger, A; Koller, U; Lochmuller, H; Krause, S; Wiche, G; Mitchell, LG; Hintner, H; Bauer, JW
J INVEST DERMATOL. 2006; 126: 32-32.
Abstracts (Zeitschrift)

2005

Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

5 xxx spliceosome-mediated RNA trans-splicing gene-therapy in epidermolysis buillosa
Wally, V; Klausegger, A; Krause, S; Lochmueller, H; Mitchell, L; Hintner, H; Bauer, J
J INVEST DERMATOL. 2005; 124(4): A80-A80.
Abstracts (Zeitschrift)

2004

Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

Hereditary angioedema in consequence of a 150 bp deletion in the 3 xxx UTR of C1-inhibitor gene
Laimer, M; Klausegger, A; Aberer, W; Wally, V; Lanschuetzer, CM; Hintner, H; Bauer, JW
J INVEST DERMATOL. 2004; 123(2):
Abstracts (Zeitschrift)
Acatalasemia: identification and characterization of a novel missense mutation
Wally, V; Buchroithner, B; Klausegger, A; Laimer, M; Hintner, H; Bauer, JW
J INVEST DERMATOL. 2004; 122(3): A85-A85.
Abstracts (Zeitschrift)

2003

Beiträge in Fachzeitschriften

Sensitization to fungi: epidemiology, comparative skin tests, and IgE reactivity of fungal extracts.
Mari, A; Schneider, P; Wally, V; Breitenbach, M; Simon-Nobbe, B;
Clin Exp Allergy. 2003; 33(10):1429-1438
Originalarbeiten (Zeitschrift)